Showing results (631-640 of 3,703) with videos related to
Sort By:
Pageof 371
Pharmacology & Therapeutics|December 23, 2008
Physiological and pharmacological implications of beta-arrestin regulationCullen L Schmid, Laura M BohnPharmacology & Therapeutics|December 27, 2008
VPAC and PAC receptors: From ligands to functionLouise Dickson, Keith FinlaysonPharmacology & Therapeutics|October 7, 2008
The potential and the pitfalls of beta-adrenoceptor agonists for the management of skeletal muscle wastingJames G Ryall, Gordon S LynchPharmacology & Therapeutics|October 24, 2007
Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapiesMegan E Kozisek, David Middlemas, David B BylundPharmacology & Therapeutics|July 12, 2008
The hERG potassium channel and hERG screening for drug-induced torsades de pointesJules C Hancox, Mark J McPate, Aziza El Harchi, et al.Pharmacology & Therapeutics|July 16, 2008
Angiotensin II: a hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talksK-D Schlüter, S WenzelPharmacology & Therapeutics|October 5, 2007
L-arginine transporters in cardiovascular disease: a novel therapeutic targetJ P F Chin-Dusting, L Willems, D M KayePharmacology & Therapeutics|October 5, 2007
The nerve growth factor and its receptors in airway inflammatory diseasesV Freund-Michel, N FrossardPharmacology & Therapeutics|August 19, 2008
The cardiac sarcolemmal ATP-sensitive potassium channel as a novel target for anti-arrhythmic therapyGeorge E BillmanPharmacology & Therapeutics|August 16, 2008
Health effects related to nanoparticle exposures: environmental, health and safety considerations for assessing hazards and risksDavid B Warheit, Christie M Sayes, Kenneth L Reed, et al.Pageof 371